FDA inspection
BeiGene (Suzhou) Co., Ltd.: FDA inspection ending Aug 28, 2019
FDA inspection 1103267 · No Action Indicated (NAI) · Suzhou
Key facts
| Inspection ID | 1103267 |
|---|---|
| Firm | BeiGene (Suzhou) Co., Ltd. |
| FEI number | 3014150588 |
| Address | Bldg 6 4th Floor, 218 Sangtian St |
| City | Suzhou |
| Fiscal year | 2019 |
| Inspection end date | Aug 28, 2019 |
| Classification | No Action Indicated (NAI) |
| Project area | New Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data